|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Szakacs G, Paterson JK, Ludwing JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Emdad L, Lebedeva IV, Su ZZ, Sarkar D,
Dent P, Curiel DT and Fisher PB: Melanoma differentiation
associated gene-7/interleukin-24 reverses multidrug resistance in
human colorectal cancer cells. Mol Cancer Ther. 6:2985–2994. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Di Nicolantonio F, Knight LA, Glaysher S,
Whitehouse PA, Mercer SJ, Sharma S, Mills L, Prin A, Johnson P,
Charlton PA, Norris D and Cree IA: Ex vivo reversal of
chemoresistance by tariquidar (XR9576). Anticancer Drugs.
15:861–869. 2004.PubMed/NCBI
|
|
5
|
Robert J and Jarry C: Multidrug resistance
reversal agents. J Med Chem. 46:4805–4817. 2003. View Article : Google Scholar
|
|
6
|
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun
S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug
resistance by targeting BCL-2 in human gastric cancer cells. Int J
Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Filipits M: Mechanisms of cancer:
multidrug resistance. Drug Discov Today Dis Mech. 1:229–234. 2004.
View Article : Google Scholar
|
|
8
|
Shi Y, Zhai H, Wang X, Han Z, Liu C, Lan
M, Du J, Guo C, Zhang Y, Wu K and Fan D: Ribosomal proteins S13 and
L23 promote multidrug resistance in gastric cancer cells by
suppressing drug-induced apoptosis. Exp Cell Res. 296:337–346.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, You H, Liu F, An H, Hi Y, Yu Q and
Fan D: Differentially expressed gene profiles between multidrug
resistant gastric adenocarcinoma cells and their parental cells.
Cancer Lett. 185:211–218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang H, Su ZZ, Lin JJ, Goldstein NI,
Young CS and Fisher PB: The melanoma differentiation associated
gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci USA.
93:9160–9165. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dash R, Bhutia SK, Azab B, Su ZZ, Quinn
BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, Yacoub A, Rahmani
M, Emdad L, Dmitriev IP, Wang XY, Sarkar D, Grant S, Dent P, Curiel
DT and Fisher PB: Mda-7/IL-24: A unique member of the IL-10 gene
family promoting cancer-targeted toxicity. Cytokine Growth Factor
Rev. 21:381–391. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gopalan B, Litvak A, Sharma S, Mhashilkar
AM, Chada S and Ramesh R: Activation of the Fas-FasL signaling
pathway by mda-7/IL-24 kills human ovarian cancer cells. Cancer
Res. 65:3017–3024. 2005.PubMed/NCBI
|
|
13
|
Li YJ, Liu G, Li Y, Vecchiarelli-Federico
LM, Liu JC, Zacksenhaus E, Shan SW, Yang BB, Li Q, Dash R, Fisher
PB, Archer MC and Ben-David Y: mda-7/IL-24 expression inhibits
breast cancer through up-regulation of growth arrest-specific
gene-3 (gas 3) and disruption of β1 integrin function. Mol Cancer
Res. 11:593–603. 2013.PubMed/NCBI
|
|
14
|
Jiang H, Lin JJ, Su ZZ, Goldstein NI and
Fisher PB: Subtraction hybridization identifies a novel melanoma
differentiation associated gene, mda-7, modulated during human
melanoma differentiation, growth and progression. Oncogene.
11:2477–2486. 1995.
|
|
15
|
Xu S, Oshima T, Imada T, Masuda M, Debnath
B, Grande F, Garofalo A and Neamati N: Stabilization of MDA-7/IL-24
for colon cancer therapy. Cancer Lett. 335:421–430. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pataer A, Chada S, Roth JA, Hunt KK and
Swisher SG: Development of Ad-mda-7/IL-24-resistant lung cancer
cell lines. Cancer Biol Ther. 7:103–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang G, Liu YQ, Wei ZP, Pei DS, Mao LJ
and Zheng JN: Enhanced anti-tumor activity by the combination of a
conditionally replicating adenovirus mediated interleukin-24 and
dacarbazine against melanoma cells via induction of apoptosis.
Cancer Lett. 294:220–228. 2010.
|
|
18
|
Tong AW, Nemunaitis J, Su D, Zhang Y,
Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K,
Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, van Wart Hood J,
Merritt J and Chada S: Intratumoral injection of INGN241, a
nonreplicating adenovector expressing the melanoma-differentiation
associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer
patients. Mol Ther. 11:160–172. 2005. View Article : Google Scholar
|
|
19
|
Xie Y, Sheng W, Miao J, Xiang J and Yang
J: Enhanced antitumor activity by combining an adenovirus harboring
ING4 with cisplatin for hepatocarcinoma cells. Cancer Gene Ther.
18:176–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishikawa T, Ramesh R, Munshi A, Chada S
and Meyn RE: Adenovirus-mediated mda-7(IL-24) gene therapy
suppresses angiogenesis and sensitizes NSCLC xenograft tumors to
radiation. Mol Ther. 9:818–828. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Cheung RM, Komaki R, Fang B and
Chang JY: Radiotherapy sensitization by tumor-specific TRAIL gene
targeting improves survival of mice bearing human non-small cell
lung cancer. Clin Cancer Res. 11:6657–6668. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moon C, Oh Y and Roth JA: Current status
of gene therapy for lung cancer and head and neck cancer. Clin
Cancer Res. 9:5055–5067. 2003.PubMed/NCBI
|
|
23
|
Xu J, Mo Y, Wang X, Liu J, Zhang X, Wang
J, Hu L, Yang C, Chen L and Wang Y: Conditionally replicative
adenovirus-based mda-7/IL-24 expression enhances sensitivity of
colon cancer cells to 5-fluorouracil and doxorubicin. J
Gastroenterol. 48:203–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang P, Zhang X, Gao Y, Ding CR, Cui F and
Jiao SC: Reversal effect of melanoma differentiation associated
gene-7/interleukin-24 on multidrug resistance in human
hepatocellular carcinoma cells. Anat Rec. 295:1639–1646. 2012.
View Article : Google Scholar
|
|
25
|
Chang S, Yang J, Cheng W, Xie Y and Sheng
W: Antitumor activity of an adenovirus harboring human IL-24 in
colon cancer. Mol Biol Rep. 38:395–401. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Ye Z, Zhong J, Xiang J and Yang J:
Adenovirus-mediated IL-24 expression suppresses hepatocellular
carcinoma growth via induction of cell apoptosis and cycling arrest
and reduction of angiogenesis. Cancer Biother Radiopharm. 22:56–63.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi JH, Lim HY, Joo HJ, Kim HS, Yi JW,
Kim HC, Cho YK, Kim MW and Lee KB: Expression of multidrug
resistance-associated protein1, P-glycoprotein, and thymidylate
synthase in gastric cancer patients treated with 5-fluorouracil and
doxorubicin-based adjuvant chemotherapy after curative resection.
Br J Cancer. 86:1578–1585. 2002. View Article : Google Scholar
|
|
29
|
Nakamura A, Nakajima G, Okuyama R,
Kuramochi H, Kondoh Y, Kanemura T, Takechi T, Yamamoto M and
Hayashi K: Enhancement of 5-fluorouracil-induced cytotoxicity by
leucovorin in 5-fluorouracil-resistant gastric cancer cells with
upregulated expression of thymidylate synthase. Gastric Cancer.
Mar..15–2013.(Epub ahead of print).
|
|
30
|
Li K, Lu Y, Liang J, Luo G, Ren G, Wang X
and Fan D: RhoE enhances multidrug resistance of gastric cancer
cells by suppressing Bax. Biochem Biophys Res Commun. 379:212–216.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao L, Pan Y, Gang Y, Wang H, Jin H, Tie
J, Xia L, Zhang Y, He L, Yao L, Qiao T, Li T, Liu Z and Fan D:
Identification of GAS1 as an epirubicin resistance-related gene in
human gastric cancer cells with a partially randomized small
interfering RNA library. J Biol Chem. 284:26273–26285. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kelland L: The resurgence of
platinum-based cancer chemotherapy. Nat Rev Cancer. 7:573–584.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chada S, Mhashilkar AM, Liu Y, Nishikawa
T, Bocangel D, Zheng M, Vorburger SA, Pataer A, Swisher SG, Rmamesh
R, Kawase K, Meyn RE and Hunt KK: mda-7 gene transfer sensitizes
breast carcinoma cells to chemotherapy, biologic therapies and
radiotherapy: Correlation with expression of bcl-2 family members.
Cancer Gene Ther. 13:490–502. 2006. View Article : Google Scholar
|
|
34
|
Eager R, Harle L and Nemunaitis J:
Ad-MDA-7; INGN 241: a review of preclinical and clinical
experience. Expert Opin Biol Ther. 8:1633–1643. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fotedar R, Diederich L and Fotedar A:
Apoptosis and the cell cycle. Prog Cell Cycle Res. 2:147–163. 1996.
View Article : Google Scholar
|
|
36
|
Dean M, Rzhetsky A and Allikmets R: The
human ATP-binding cassette (ABC) transporter superfamily. Genome
Res. 11:1156–1166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Juliano RL and Ling V: A surface
glycoprotein modulating drug permeability in chinese hamster ovary
cell mutants. Biochim Biophys Acta. 455:152–162. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ueda K, Cardarelli C, Gottesman MM and
Pastan I: Expression of a full-length cDNA for the human ‘MDR1’
gene confers resistance to colchicine, doxorubicin, and
vinblastine. Proc Natl Acad Sci USA. 84:3004–3008. 1987.
|
|
39
|
Gottesman MM and Ling V: The molecular
basis of multidrug resistance in cancer: the early years of
P-glycoprotein research. FEBS Lett. 580:998–1009. 2006.PubMed/NCBI
|
|
40
|
Antonsson B and Martinou JC: The Bcl-2
protein family. Exp Cell Res. 256:50–57. 2000. View Article : Google Scholar
|
|
41
|
Eberle J, Kurbanov BM, Hossini AM, Trefzer
U and Fecker LF: Overcoming apoptosis deficiency of melanoma-hope
for new therapeutic approaches. Drug Resist Updat. 10:218–234.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang L, Ming L and Yu J: BH3 mimetics to
improve cancer therapy: mechanisms and examples. Drug Resist Updat.
10:207–217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhu W, Shan X, Wang T, Shu Y and Liu P:
miR-181b modulates multidrug resistance by targeting BCL2 in human
cancer cell lines. Int J Cancer. 127:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Michl P and Downward J: Mechanisms of
disease: PI3K/AKT signaling in gastrointestinal cancers. Z
Gastroenterol. 43:1133–1139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han Z, Hong L, Han Y, Wu K, Han S, Shen H,
Li C, Yao L, Qiao T and Fan D: Phospho Akt mediates multidrug
resistance of gastric cancer cells through regulation of P-gp,
Bcl-2 and Bax. J Exp Clin Cancer Res. 26:261–268. 2007.PubMed/NCBI
|
|
46
|
Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li
JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo
HS and Yu JP: Phosphoinositide3-kinase/Akt pathway plays an
important role in chemoresistance of gastric cancer cells against
etoposide and doxorubicin induced cell death. Int J Cancer.
122:433–443. 2008. View Article : Google Scholar : PubMed/NCBI
|
